Genetic engineering concept. Medical science. Scientific Laboratory.

Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx

Posted on

STONY BROOK, NY. August 12, 2019 – LineaRx, Inc. (“LineaRx”), a majority-owned subsidiary of Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) announced that, in a decision rendered on August 7, 2019, the Centers for Medicare and Medicaid Services (CMS) approved chimeric antigen receptor (CAR) T-cell therapies that fit the CMS criteria […]

Read More email